259 related articles for article (PubMed ID: 32939338)
1. The CRISPR-Cas9 crATIC HeLa transcriptome: Characterization of a novel cellular model of ATIC deficiency and ZMP accumulation.
Mazzarino RC; Baresova V; Zikánová M; Duval N; Wilkinson TG; Patterson D; Vacano GN
Mol Genet Metab Rep; 2020 Dec; 25():100642. PubMed ID: 32939338
[TBL] [Abstract][Full Text] [Related]
2. The CRISPR-Cas9 crADSL HeLa transcriptome: A first step in establishing a model for ADSL deficiency and SAICAR accumulation.
Mazzarino RC; Baresova V; Zikánová M; Duval N; Wilkinson TG; Patterson D; Vacano GN
Mol Genet Metab Rep; 2019 Dec; 21():100512. PubMed ID: 31516833
[TBL] [Abstract][Full Text] [Related]
3. Mapping of the bovine genes of the de novo AMP synthesis pathway.
Bønsdorff T; Gautier M; Farstad W; Rønningen K; Lingaas F; Olsaker I
Anim Genet; 2004 Dec; 35(6):438-44. PubMed ID: 15566465
[TBL] [Abstract][Full Text] [Related]
4. Case report of a rare purine synthesis disorder due to 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICAR) deficiency.
Joy P; Madhuri V; Palocaren T; Das S; Susan Cleave Abraham S; Korula S; Koshy B; Jose J; Chandran M; Danda S
Brain Dev; 2022 Oct; 44(9):645-649. PubMed ID: 35637059
[TBL] [Abstract][Full Text] [Related]
5. Disorders of purine biosynthesis metabolism.
Dewulf JP; Marie S; Nassogne MC
Mol Genet Metab; 2022 Jul; 136(3):190-198. PubMed ID: 34998670
[TBL] [Abstract][Full Text] [Related]
6. Genetic and metabolomic analysis of AdeD and AdeI mutants of de novo purine biosynthesis: cellular models of de novo purine biosynthesis deficiency disorders.
Duval N; Luhrs K; Wilkinson TG; Baresova V; Skopova V; Kmoch S; Vacano GN; Zikanova M; Patterson D
Mol Genet Metab; 2013 Mar; 108(3):178-189. PubMed ID: 23394948
[TBL] [Abstract][Full Text] [Related]
7. Metabolites of De Novo Purine Synthesis: Metabolic Regulators and Cytotoxic Compounds.
Souckova O; Skopova V; Baresova V; Sedlak D; Bleyer AJ; Kmoch S; Zikanova M
Metabolites; 2022 Dec; 12(12):. PubMed ID: 36557247
[TBL] [Abstract][Full Text] [Related]
8. 5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells.
Sabina RL; Patterson D; Holmes EW
J Biol Chem; 1985 May; 260(10):6107-14. PubMed ID: 3997815
[TBL] [Abstract][Full Text] [Related]
9. AICAR transformylase/IMP cyclohydrolase (ATIC) is essential for de novo purine biosynthesis and infection by Cryptococcus neoformans.
Wizrah MSI; Chua SMH; Luo Z; Manik MK; Pan M; Whyte JML; Robertson AAB; Kappler U; Kobe B; Fraser JA
J Biol Chem; 2022 Oct; 298(10):102453. PubMed ID: 36063996
[TBL] [Abstract][Full Text] [Related]
10. AMPK Activation via Modulation of De Novo Purine Biosynthesis with an Inhibitor of ATIC Homodimerization.
Asby DJ; Cuda F; Beyaert M; Houghton FD; Cagampang FR; Tavassoli A
Chem Biol; 2015 Jul; 22(7):838-48. PubMed ID: 26144885
[TBL] [Abstract][Full Text] [Related]
11. Lesch-Nyhan syndrome: the synthesis of inosine 5'-phosphate in the hypoxanthine-guanine phosphoribosyltransferase-deficient erythrocyte by alternate biochemical pathways.
Lowy BA; Williams MK
Pediatr Res; 1977 May; 11(5):691-4. PubMed ID: 870876
[TBL] [Abstract][Full Text] [Related]
12. AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
Marie S; Heron B; Bitoun P; Timmerman T; Van Den Berghe G; Vincent MF
Am J Hum Genet; 2004 Jun; 74(6):1276-81. PubMed ID: 15114530
[TBL] [Abstract][Full Text] [Related]
13. Substrate cycling between 5-amino-4-imidazolecarboxamide riboside and its monophosphate in isolated rat hepatocytes.
Vincent MF; Bontemps F; Van den Berghe G
Biochem Pharmacol; 1996 Oct; 52(7):999-1006. PubMed ID: 8831718
[TBL] [Abstract][Full Text] [Related]
14. Is ZMP the toxic metabolite in Lesch-Nyhan disease?
López JM
Med Hypotheses; 2008 Nov; 71(5):657-63. PubMed ID: 18710792
[TBL] [Abstract][Full Text] [Related]
15. Dietary intake of fructose increases purine
Zhang P; Sun H; Cheng X; Li Y; Zhao Y; Mei W; Wei X; Zhou H; Du Y; Zeng C
Front Nutr; 2022; 9():1045805. PubMed ID: 36601078
[TBL] [Abstract][Full Text] [Related]
16. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
[TBL] [Abstract][Full Text] [Related]
17. Purine synthesis suppression reduces the development and progression of pulmonary hypertension in rodent models.
Ma Q; Yang Q; Xu J; Sellers HG; Brown ZL; Liu Z; Bordan Z; Shi X; Zhao D; Cai Y; Pareek V; Zhang C; Wu G; Dong Z; Verin AD; Gan L; Du Q; Benkovic SJ; Xu S; Asara JM; Ben-Sahra I; Barman S; Su Y; Fulton DJR; Huo Y
Eur Heart J; 2023 Apr; 44(14):1265-1279. PubMed ID: 36721994
[TBL] [Abstract][Full Text] [Related]
18. The last enzyme of the de novo purine synthesis pathway 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) plays a central role in insulin signaling and the Golgi/endosomes protein network.
Boutchueng-Djidjou M; Collard-Simard G; Fortier S; Hébert SS; Kelly I; Landry CR; Faure RL
Mol Cell Proteomics; 2015 Apr; 14(4):1079-92. PubMed ID: 25687571
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome and metabolome analysis of crGART, a novel cell model of de novo purine synthesis deficiency: Alterations in CD36 expression and activity.
Mazzarino RC; Baresova V; Zikánová M; Duval N; Wilkinson TG; Patterson D; Vacano GN
PLoS One; 2021; 16(7):e0247227. PubMed ID: 34283828
[TBL] [Abstract][Full Text] [Related]
20. Characterization of AICAR transformylase/IMP cyclohydrolase (ATIC) from Staphylococcus lugdunensis.
Verma P; Kar B; Varshney R; Roy P; Sharma AK
FEBS J; 2017 Dec; 284(24):4233-4261. PubMed ID: 29063699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
